Abstract
Four-factor prothrombin complex concentrate is approved for use of life-threatening bleeding secondary to vitamin K antagonism in adults. We describe the use of four-factor prothrombin complex concentrate for hemostasis in a 6-week-old child with life-threatening vitamin K dependent-bleeding who never received vitamin K prophylaxis at birth.
Original language | English (US) |
---|---|
Pages (from-to) | 1443-1444 |
Number of pages | 2 |
Journal | journal of pediatrics |
DOIs | |
State | Accepted/In press - 2020 |
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health